ATH3NA

PLANS

Choose the level of analysis you need.

Three clear levels for journalling, performance analysis and approved market context.

Journal

£24/month

£240 annually
  • Trading Journal
  • Daily Targets and Planning
  • Execution Discipline
  • Behaviour Observations
  • Daily Reviews
Learn more

Performance

£44/month

£440 annually
  • Everything in Journal
  • Multiple Trading Accounts
  • Advanced Performance Analytics
  • Ticker and Time-of-Day Analysis
  • Weekly Reviews
Learn more

Intelligence

£89/month

£890 annually
  • Everything in Performance
  • ATH3NA Daily Market View
  • ETF Market Context
  • Scenarios and Risk Conditions
  • Approved Market View Archive
Learn more

ADVANCED ACCESS

Controlled access beyond the public plans.

Professional and Institutional are informational access levels only. Neither can be purchased or activated publicly.

ATH3NA PROFESSIONAL

Deeper analytical access for professional workflows.

Designed for experienced traders, analysts, portfolio professionals and advanced market participants who require a broader analytical workspace.

Status
Private access
Access
By application
Pricing
Pricing subject to data-licensing configuration

No analytical modules are currently approved for customer activation at this access level.

ATH3NA Professional is a product-access level. It does not represent a customer’s legal or regulatory classification.

Professional details

ATH3NA INSTITUTIONAL

Controlled analytical infrastructure for professional teams.

A contract-led structure for professional trading organisations, family offices, analytical teams, research teams, regulated firms and corporate market teams.

Status
Contract-led
Access
Controlled private discussion
Pricing
Pricing by agreement

No analytical modules are currently approved for customer activation at this access level.

Institutional access is currently available only through controlled private discussion after the required legal and licensing review.

Institutional details

Market View availability is subject to data licensing, regulatory review, editorial approval and plan eligibility.